C85.07 Lymphosarcoma, spleen

Name of the Condition

• Lymphosarcoma, spleen
• C85.07

Summary

Lymphosarcoma, spleen, is a type of non-Hodgkin lymphoma (NHL) that specifically involves the spleen. This condition affects the lymphatic system, part of the immune system, and involves abnormal growth of lymphoid cells. The term "lymphosarcoma" is a historical classification now categorized under NHL.

Causes

The exact cause of lymphosarcoma in the spleen is often unknown but involves genetic mutations in lymphocytes. Factors such as viral infections, immune system disorders, or exposure to certain chemicals may contribute to its development. These mutations disrupt normal cell regulation, leading to uncontrolled growth.

Risk Factors

• Advanced age (more common in older adults)
• Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
• Certain infections (e.g., Epstein-Barr virus, H. pylori)
• Exposure to chemicals (e.g., pesticides, herbicides)
• Family history of lymphoma
• Autoimmune conditions (e.g., rheumatoid arthritis)

Symptoms

• Enlarged spleen (splenomegaly) causing abdominal pain or fullness
• Fever, night sweats, or unexplained weight loss
• Fatigue or weakness
• Easy bruising or bleeding (due to low platelet counts)
• Anemia (causing pale skin or shortness of breath)
• Loss of appetite

Diagnosis

Diagnosis typically involves a combination of physical examination, imaging studies (e.g., CT or MRI of the abdomen), and biopsy of the spleen or affected lymph nodes. Blood tests may also be performed to assess cell counts and detect abnormal cells. A pathologist examines the tissue sample to confirm the presence of lymphoma and determine its subtype.

Treatment Options

Treatment depends on the stage and aggressiveness of the lymphoma and may include chemotherapy, immunotherapy, targeted therapy, or radiation therapy. In some cases, splenectomy (surgical removal of the spleen) may be considered. Treatment plans are tailored to the individual patient’s condition and overall health.

Prognosis and Follow-Up

Prognosis varies based on factors such as the lymphoma subtype, stage at diagnosis, and response to treatment. Regular follow-up appointments are essential to monitor for recurrence or complications. Long-term surveillance may include periodic imaging and blood tests.

Complications

• Splenic rupture (rare but serious)
• Increased risk of infections (due to reduced immune function)
• Anemia or thrombocytopenia (low platelet count)
• Organ damage from tumor growth or treatment side effects

Lifestyle & Prevention

• Maintain a balanced diet to support overall health
• Practice good hygiene to reduce infection risk
• Avoid known carcinogens (e.g., tobacco, excessive alcohol)
• Stay up-to-date with vaccinations (as recommended by a healthcare provider)
• Manage stress through relaxation techniques or exercise

When to Seek Professional Help

Seek medical attention if you experience persistent abdominal pain, unexplained weight loss, fever, night sweats, or signs of infection (e.g., fever, chills). Prompt evaluation is important for early diagnosis and treatment.

Tips for Medical Coders

When coding for lymphosarcoma of the spleen (C85.07), ensure documentation specifies the spleen as the primary site. Verify that the diagnosis aligns with clinical findings and that any relevant details (e.g., stage, treatment) are clearly documented. Follow ICD-10-CM guidelines for coding lymphoma by site and avoid using this code for unspecified or other site lymphosarcoma.